Biological Response of Treatment with Saffron Petal Extract on Cytokine-Induced Oxidative Stress and Inflammation in the Caco-2/Human Leukemia Monocytic Co-Culture Model
- PMID: 39456510
- PMCID: PMC11504373
- DOI: 10.3390/antiox13101257
Biological Response of Treatment with Saffron Petal Extract on Cytokine-Induced Oxidative Stress and Inflammation in the Caco-2/Human Leukemia Monocytic Co-Culture Model
Abstract
The pathogenesis of Inflammatory Bowel Disease (IBD) involves complex mechanisms, including immune dysregulation, gut microbiota imbalances, oxidative stress, and defects in the gastrointestinal mucosal barrier. Current treatments for IBD often have significant limitations and adverse side effects, prompting a search for alternative therapeutic strategies. Natural products with anti-inflammatory and antioxidant properties have demonstrated potential for IBD management. There is increasing interest in exploring food industry waste as a source of bioactive molecules with healthcare applications. In this study, a co-culture system of Caco-2 cells and PMA-differentiated THP-1 macrophages was used to simulate the human intestinal microenvironment. Inflammation was induced using TNF-α and IFN-γ, followed by treatment with Saffron Petal Extract (SPE). The results demonstrated that SPE significantly attenuated oxidative stress and inflammation by downregulating the expression of pro-inflammatory mediators such as iNOS, COX-2, IL-1β, and IL-6 via modulation of the NF-κB pathway. Given that NF-κB is a key regulator of macrophage-driven inflammation, our findings support further investigation of SPE as a potential complementary therapeutic agent for IBD treatment.
Keywords: inflammation; inflammatory bowel disease; oxidative stress; saffron; saffron petal extract.
Conflict of interest statement
The authors declare no conflicts of interest. The author Maria Anna Maggi is from the Hortus Novus company. The company had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Santiago M., Stocker F., Ministro P., Gonçalves R., Carvalho D., Portela F., Correia L., Lago P., Trindade E., Dias C.C., et al. Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World? Clin. Transl. Gastroenterol. 2022;13:e00481. doi: 10.14309/ctg.0000000000000481. - DOI - PMC - PubMed
-
- Alemany-Cosme E., Sáez-González E., Moret I., Mateos B., Iborra M., Nos P., Sandoval J., Beltrán B. Oxidative Stress in the Pathogenesis of Crohn’s Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants. 2021;10:64. doi: 10.3390/antiox10010064. - DOI - PMC - PubMed
-
- Manrai M., Jha A.A., Dawra S., Pachisia A.V. Biologics, piccole molecole e altro nella malattia infiammatoria intestinale: Il presente e il futuro. Future Pharmacol. 2024;4:279–316. doi: 10.3390/futurepharmacol4010017. - DOI
LinkOut - more resources
Full Text Sources
Research Materials
